AMS - 2020-07PDcc-Pediatrics – Critical Care: Life-Threatening Infections; Seizures; Flaccid Myelitis

$119.00$189.00

5 AMA PRA Category 1 Credits™
$119.00
$189.00
StreamingINCLUDED

Title: PDcc-Pediatrics – Critical Care: Life-Threatening Infections; Seizures; Flaccid Myelitis

Faculty:Robert A. Belfer, M.D., Michael J. Muszynski, M.D., F.A.A.P.

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: Life-Threatening Pediatric Infections.

Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP

  1. Conclude that as newer immunizations eradicate many serious infections, we are still faced with certain pathogens that can cause severe morbidity and mortality.
  2. Recognize, diagnose and manage the following diseases:
    1. Toxic Shock Syndrome;
    2. Meningococcemia;
    3. Rocky Mountain Spotted Fever;
    4. Kawasaki Syndrome.
  3. Develop an approach to the patient who presents with fever and a rash.

TOPIC 2: Pediatric Seizures I. Status Epilepticus, II. Febrile Seizures.

Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of

Pediatrics, the participant should be able to: EBM, GL, COMP

  1. Demonstrate appropriate medications to treat pediatric status epilepticus.
  2. Utilize the literature concerning epidemiology of febrile seizures in educating patients’ families.

TOPIC 3: Acute Flaccid Myelitis. 

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Recognize the clinical manifestations of AFM and apply the clinical, laboratory, and case classification criteria as defined by the Centers for Disease Control (CDC).
  2. Compare other known neurological entities in the differential diagnosis of a patient with suspected AFM.
  3. Recommend appropriate diagnostic testing for AFM and reporting method to health authorities.
  4. Apply the interim considerations for clinical management of AFM according to the latest expert opinion defined by CDC.
Total Cost: $

Title: PDcc-Pediatrics – Critical Care: Life-Threatening Infections; Seizures; Flaccid Myelitis

Faculty:Robert A. Belfer, M.D., Michael J. Muszynski, M.D., F.A.A.P.

Original Release Date: July 1, 2020  Expiration Date: July 1, 2023

TOPIC 1: Life-Threatening Pediatric Infections.

Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP

  1. Conclude that as newer immunizations eradicate many serious infections, we are still faced with certain pathogens that can cause severe morbidity and mortality.
  2. Recognize, diagnose and manage the following diseases:
    1. Toxic Shock Syndrome;
    2. Meningococcemia;
    3. Rocky Mountain Spotted Fever;
    4. Kawasaki Syndrome.
  3. Develop an approach to the patient who presents with fever and a rash.

TOPIC 2: Pediatric Seizures I. Status Epilepticus, II. Febrile Seizures.

Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of

Pediatrics, the participant should be able to: EBM, GL, COMP

  1. Demonstrate appropriate medications to treat pediatric status epilepticus.
  2. Utilize the literature concerning epidemiology of febrile seizures in educating patients’ families.

TOPIC 3: Acute Flaccid Myelitis. 

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Recognize the clinical manifestations of AFM and apply the clinical, laboratory, and case classification criteria as defined by the Centers for Disease Control (CDC).
  2. Compare other known neurological entities in the differential diagnosis of a patient with suspected AFM.
  3. Recommend appropriate diagnostic testing for AFM and reporting method to health authorities.
  4. Apply the interim considerations for clinical management of AFM according to the latest expert opinion defined by CDC.